nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—Sinus tachycardia—Epirubicin—bone cancer	0.00549	0.0271	CcSEcCtD
Bepridil—Loss of libido—Methotrexate—bone cancer	0.00512	0.0253	CcSEcCtD
Bepridil—Sinus tachycardia—Doxorubicin—bone cancer	0.00508	0.0251	CcSEcCtD
Bepridil—Sudden death—Methotrexate—bone cancer	0.00462	0.0228	CcSEcCtD
Bepridil—Pain—Carboplatin—bone cancer	0.00448	0.0221	CcSEcCtD
Bepridil—Body temperature increased—Carboplatin—bone cancer	0.00414	0.0205	CcSEcCtD
Bepridil—Ventricular arrhythmia—Epirubicin—bone cancer	0.00299	0.0148	CcSEcCtD
Bepridil—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00277	0.0137	CcSEcCtD
Bepridil—Abdominal discomfort—Cisplatin—bone cancer	0.00259	0.0128	CcSEcCtD
Bepridil—Vasodilation—Epirubicin—bone cancer	0.00252	0.0124	CcSEcCtD
Bepridil—Vasodilation procedure—Epirubicin—bone cancer	0.00252	0.0124	CcSEcCtD
Bepridil—Vasodilation—Doxorubicin—bone cancer	0.00233	0.0115	CcSEcCtD
Bepridil—Vasodilation procedure—Doxorubicin—bone cancer	0.00233	0.0115	CcSEcCtD
Bepridil—Ventricular tachycardia—Epirubicin—bone cancer	0.00221	0.0109	CcSEcCtD
Bepridil—Bradycardia—Cisplatin—bone cancer	0.0022	0.0109	CcSEcCtD
Bepridil—Ventricular tachycardia—Doxorubicin—bone cancer	0.00205	0.0101	CcSEcCtD
Bepridil—Tinnitus—Cisplatin—bone cancer	0.00202	0.00997	CcSEcCtD
Bepridil—Cardiac disorder—Cisplatin—bone cancer	0.00201	0.00992	CcSEcCtD
Bepridil—Arrhythmia—Cisplatin—bone cancer	0.00193	0.00955	CcSEcCtD
Bepridil—Flatulence—Cisplatin—bone cancer	0.00186	0.00917	CcSEcCtD
Bepridil—Vision blurred—Cisplatin—bone cancer	0.00178	0.00877	CcSEcCtD
Bepridil—Tremor—Cisplatin—bone cancer	0.00176	0.00872	CcSEcCtD
Bepridil—Increased appetite—Epirubicin—bone cancer	0.00171	0.00845	CcSEcCtD
Bepridil—Cardiac failure—Epirubicin—bone cancer	0.00165	0.00813	CcSEcCtD
Bepridil—Myalgia—Cisplatin—bone cancer	0.0016	0.00792	CcSEcCtD
Bepridil—Anxiety—Cisplatin—bone cancer	0.0016	0.00789	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—bone cancer	0.00158	0.00783	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—bone cancer	0.00158	0.00781	CcSEcCtD
Bepridil—Oedema—Cisplatin—bone cancer	0.00154	0.00759	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—bone cancer	0.00152	0.00752	CcSEcCtD
Bepridil—Hyperhidrosis—Cisplatin—bone cancer	0.00149	0.00734	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—bone cancer	0.00148	0.00733	CcSEcCtD
Bepridil—Anorexia—Cisplatin—bone cancer	0.00147	0.00724	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—bone cancer	0.00142	0.00703	CcSEcCtD
Bepridil—Gastritis—Epirubicin—bone cancer	0.00142	0.00702	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.0014	0.00692	CcSEcCtD
Bepridil—Influenza—Epirubicin—bone cancer	0.00139	0.00686	CcSEcCtD
Bepridil—Paraesthesia—Cisplatin—bone cancer	0.00138	0.00682	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—bone cancer	0.00137	0.00678	CcSEcCtD
Bepridil—Dyspnoea—Cisplatin—bone cancer	0.00137	0.00677	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—bone cancer	0.00137	0.00675	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—bone cancer	0.00135	0.00668	CcSEcCtD
Bepridil—Decreased appetite—Cisplatin—bone cancer	0.00134	0.0066	CcSEcCtD
Bepridil—Gastrointestinal disorder—Cisplatin—bone cancer	0.00133	0.00656	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—bone cancer	0.00132	0.00653	CcSEcCtD
Bepridil—Depression—Methotrexate—bone cancer	0.00132	0.00651	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—bone cancer	0.00132	0.0065	CcSEcCtD
Bepridil—Pain—Cisplatin—bone cancer	0.00131	0.00649	CcSEcCtD
Bepridil—Influenza—Doxorubicin—bone cancer	0.00128	0.00635	CcSEcCtD
Bepridil—Sweating—Methotrexate—bone cancer	0.00127	0.00626	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—bone cancer	0.00125	0.00618	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—bone cancer	0.00124	0.00611	CcSEcCtD
Bepridil—Body temperature increased—Cisplatin—bone cancer	0.00122	0.006	CcSEcCtD
Bepridil—Sweating—Epirubicin—bone cancer	0.00119	0.00586	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—bone cancer	0.00118	0.00582	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—bone cancer	0.00115	0.00566	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—bone cancer	0.00113	0.00559	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—bone cancer	0.00111	0.0055	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—bone cancer	0.00111	0.00547	CcSEcCtD
Bepridil—Asthenia—Cisplatin—bone cancer	0.0011	0.00545	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—bone cancer	0.0011	0.00545	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—bone cancer	0.0011	0.00544	CcSEcCtD
Bepridil—Sweating—Doxorubicin—bone cancer	0.0011	0.00542	CcSEcCtD
Bepridil—Diarrhoea—Cisplatin—bone cancer	0.00105	0.0052	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—bone cancer	0.00105	0.00517	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—bone cancer	0.00104	0.00512	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—bone cancer	0.00103	0.00509	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—bone cancer	0.00103	0.00509	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—bone cancer	0.00102	0.00504	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—bone cancer	0.000993	0.0049	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—bone cancer	0.000974	0.00481	CcSEcCtD
Bepridil—Rash—Cisplatin—bone cancer	0.000969	0.00479	CcSEcCtD
Bepridil—Dermatitis—Cisplatin—bone cancer	0.000968	0.00478	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—bone cancer	0.000959	0.00474	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—bone cancer	0.000954	0.00471	CcSEcCtD
Bepridil—Flatulence—Epirubicin—bone cancer	0.000953	0.00471	CcSEcCtD
Bepridil—Tension—Epirubicin—bone cancer	0.000949	0.00469	CcSEcCtD
Bepridil—Nervousness—Epirubicin—bone cancer	0.000939	0.00464	CcSEcCtD
Bepridil—Vertigo—Methotrexate—bone cancer	0.000929	0.00459	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—bone cancer	0.000918	0.00454	CcSEcCtD
Bepridil—Nausea—Cisplatin—bone cancer	0.000913	0.00451	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—bone cancer	0.000912	0.0045	CcSEcCtD
Bepridil—Cough—Methotrexate—bone cancer	0.000902	0.00446	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—bone cancer	0.000882	0.00436	CcSEcCtD
Bepridil—Myalgia—Methotrexate—bone cancer	0.00088	0.00435	CcSEcCtD
Bepridil—Tension—Doxorubicin—bone cancer	0.000878	0.00434	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—bone cancer	0.000869	0.00429	CcSEcCtD
Bepridil—Vertigo—Epirubicin—bone cancer	0.000869	0.00429	CcSEcCtD
Bepridil—Dextropropoxyphene—CYP3A4—bone cancer	0.000867	0.27	CrCbGaD
Bepridil—Syncope—Epirubicin—bone cancer	0.000867	0.00429	CcSEcCtD
Bepridil—Fentanyl—CYP3A4—bone cancer	0.000858	0.267	CrCbGaD
Bepridil—Palpitations—Epirubicin—bone cancer	0.000855	0.00422	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—bone cancer	0.00085	0.0042	CcSEcCtD
Bepridil—Cough—Epirubicin—bone cancer	0.000844	0.00417	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—bone cancer	0.000843	0.00417	CcSEcCtD
Bepridil—Hypertension—Epirubicin—bone cancer	0.000835	0.00413	CcSEcCtD
Bepridil—Myalgia—Epirubicin—bone cancer	0.000823	0.00407	CcSEcCtD
Bepridil—Anxiety—Epirubicin—bone cancer	0.000821	0.00405	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—bone cancer	0.000815	0.00403	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—bone cancer	0.000805	0.00398	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—bone cancer	0.000804	0.00397	CcSEcCtD
Bepridil—Anorexia—Methotrexate—bone cancer	0.000804	0.00397	CcSEcCtD
Bepridil—Syncope—Doxorubicin—bone cancer	0.000803	0.00396	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—bone cancer	0.000791	0.00391	CcSEcCtD
Bepridil—Oedema—Epirubicin—bone cancer	0.000789	0.0039	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—bone cancer	0.000787	0.00389	CcSEcCtD
Bepridil—Cough—Doxorubicin—bone cancer	0.000781	0.00386	CcSEcCtD
Bepridil—Shock—Epirubicin—bone cancer	0.000777	0.00384	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—bone cancer	0.000773	0.00382	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000769	0.0038	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—bone cancer	0.000763	0.00377	CcSEcCtD
Bepridil—Insomnia—Methotrexate—bone cancer	0.000763	0.00377	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—bone cancer	0.000762	0.00376	CcSEcCtD
Bepridil—Benzphetamine—CYP3A4—bone cancer	0.000761	0.237	CrCbGaD
Bepridil—Anxiety—Doxorubicin—bone cancer	0.000759	0.00375	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—bone cancer	0.000757	0.00374	CcSEcCtD
Bepridil—Anorexia—Epirubicin—bone cancer	0.000752	0.00372	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—bone cancer	0.000752	0.00372	CcSEcCtD
Bepridil—Somnolence—Methotrexate—bone cancer	0.00075	0.0037	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—bone cancer	0.000745	0.00368	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—bone cancer	0.000743	0.00367	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—bone cancer	0.000733	0.00362	CcSEcCtD
Bepridil—Oedema—Doxorubicin—bone cancer	0.00073	0.00361	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—bone cancer	0.000728	0.0036	CcSEcCtD
Bepridil—Phenoxybenzamine—CYP3A4—bone cancer	0.000727	0.226	CrCbGaD
Bepridil—Pain—Methotrexate—bone cancer	0.000721	0.00356	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000719	0.00355	CcSEcCtD
Bepridil—Shock—Doxorubicin—bone cancer	0.000719	0.00355	CcSEcCtD
Bepridil—Insomnia—Epirubicin—bone cancer	0.000714	0.00353	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—bone cancer	0.000709	0.0035	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—bone cancer	0.000706	0.00349	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—bone cancer	0.000704	0.00348	CcSEcCtD
Bepridil—Somnolence—Epirubicin—bone cancer	0.000702	0.00347	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—bone cancer	0.000696	0.00344	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—bone cancer	0.000695	0.00343	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—bone cancer	0.00069	0.00341	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—bone cancer	0.000686	0.00339	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—bone cancer	0.000682	0.00337	CcSEcCtD
Bepridil—Constipation—Epirubicin—bone cancer	0.000675	0.00333	CcSEcCtD
Bepridil—Pain—Epirubicin—bone cancer	0.000675	0.00333	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—bone cancer	0.000667	0.00329	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—bone cancer	0.000667	0.00329	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000665	0.00329	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—bone cancer	0.000661	0.00326	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—bone cancer	0.000656	0.00324	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—bone cancer	0.000651	0.00322	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—bone cancer	0.000649	0.00321	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—bone cancer	0.000645	0.00319	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—bone cancer	0.000643	0.00318	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—bone cancer	0.000635	0.00314	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000631	0.00312	CcSEcCtD
Bepridil—Pain—Doxorubicin—bone cancer	0.000625	0.00309	CcSEcCtD
Bepridil—Constipation—Doxorubicin—bone cancer	0.000625	0.00309	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—bone cancer	0.000624	0.00308	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—bone cancer	0.000624	0.00308	CcSEcCtD
Bepridil—Asthenia—Methotrexate—bone cancer	0.000605	0.00299	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—bone cancer	0.000597	0.00295	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—bone cancer	0.000577	0.00285	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—bone cancer	0.000577	0.00285	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—bone cancer	0.000577	0.00285	CcSEcCtD
Bepridil—Asthenia—Epirubicin—bone cancer	0.000566	0.0028	CcSEcCtD
Bepridil—Dizziness—Methotrexate—bone cancer	0.000558	0.00276	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—bone cancer	0.00054	0.00267	CcSEcCtD
Bepridil—Rash—Methotrexate—bone cancer	0.000532	0.00263	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—bone cancer	0.000531	0.00263	CcSEcCtD
Bepridil—Headache—Methotrexate—bone cancer	0.000528	0.00261	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—bone cancer	0.000524	0.00259	CcSEcCtD
Bepridil—Dizziness—Epirubicin—bone cancer	0.000522	0.00258	CcSEcCtD
Bepridil—Nausea—Methotrexate—bone cancer	0.000501	0.00248	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—bone cancer	0.0005	0.00247	CcSEcCtD
Bepridil—Rash—Epirubicin—bone cancer	0.000498	0.00246	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—bone cancer	0.000497	0.00246	CcSEcCtD
Bepridil—Headache—Epirubicin—bone cancer	0.000495	0.00244	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—bone cancer	0.000483	0.00239	CcSEcCtD
Bepridil—Nausea—Epirubicin—bone cancer	0.000469	0.00232	CcSEcCtD
Bepridil—Rash—Doxorubicin—bone cancer	0.000461	0.00228	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—bone cancer	0.00046	0.00227	CcSEcCtD
Bepridil—Headache—Doxorubicin—bone cancer	0.000458	0.00226	CcSEcCtD
Bepridil—Nausea—Doxorubicin—bone cancer	0.000434	0.00214	CcSEcCtD
Bepridil—PDE1A—Disease—KIT—bone cancer	0.000252	0.000317	CbGpPWpGaD
Bepridil—CALM3—Signaling by ERBB2—EGFR—bone cancer	0.000252	0.000317	CbGpPWpGaD
Bepridil—CALM3—DAP12 signaling—EGFR—bone cancer	0.00025	0.000315	CbGpPWpGaD
Bepridil—PDE1B—Immune System—KIT—bone cancer	0.00025	0.000315	CbGpPWpGaD
Bepridil—CALM2—Downstream signal transduction—EGFR—bone cancer	0.000246	0.000309	CbGpPWpGaD
Bepridil—CALM1—Downstream signal transduction—EGFR—bone cancer	0.000246	0.000309	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000246	0.000309	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—EGFR—bone cancer	0.000245	0.000308	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR—EGFR—bone cancer	0.000245	0.000308	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IGF1R—bone cancer	0.000244	0.000307	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—EGFR—bone cancer	0.000243	0.000306	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—EGFR—bone cancer	0.000243	0.000306	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—EGFR—bone cancer	0.000242	0.000305	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—EGFR—bone cancer	0.000242	0.000305	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—MDM2—bone cancer	0.00024	0.000302	CbGpPWpGaD
Bepridil—PDE1A—Disease—BRAF—bone cancer	0.000237	0.000298	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000237	0.000298	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFBR2—bone cancer	0.000237	0.000298	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000236	0.000297	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—EGFR—bone cancer	0.000236	0.000297	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—EGFR—bone cancer	0.000236	0.000297	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—TP53—bone cancer	0.000235	0.000296	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—EGFR—bone cancer	0.000235	0.000296	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—MDM2—bone cancer	0.000235	0.000296	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—EGFR—bone cancer	0.000233	0.000294	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—MDM2—bone cancer	0.000232	0.000292	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—MDM2—bone cancer	0.000232	0.000292	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000231	0.000291	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—PTGS2—bone cancer	0.000231	0.000291	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—EGFR—bone cancer	0.000231	0.000291	CbGpPWpGaD
Bepridil—PDE1B—Disease—KIT—bone cancer	0.000231	0.00029	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—EGFR—bone cancer	0.00023	0.00029	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—EGFR—bone cancer	0.000228	0.000287	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—MDM2—bone cancer	0.000227	0.000286	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—MDM2—bone cancer	0.000227	0.000286	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—EGFR—bone cancer	0.000226	0.000284	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—EGFR—bone cancer	0.000226	0.000284	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—SMO—bone cancer	0.000224	0.000282	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000224	0.000282	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000224	0.000282	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—EGFR—bone cancer	0.000223	0.000281	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—EGFR—bone cancer	0.000223	0.000281	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IGF1R—bone cancer	0.000223	0.00028	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—EGFR—bone cancer	0.000218	0.000274	CbGpPWpGaD
Bepridil—PDE1B—Disease—BRAF—bone cancer	0.000217	0.000273	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—SMO—bone cancer	0.000217	0.000273	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—SMO—bone cancer	0.000217	0.000273	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RGS1—bone cancer	0.000217	0.000273	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GRM4—bone cancer	0.000217	0.000273	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—TP53—bone cancer	0.000215	0.000271	CbGpPWpGaD
Bepridil—PDE1A—Immune System—MDM2—bone cancer	0.000215	0.000271	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000214	0.000269	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—PLAU—bone cancer	0.000212	0.000267	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—EGFR—bone cancer	0.000211	0.000265	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—EGFR—bone cancer	0.000211	0.000265	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RGS1—bone cancer	0.00021	0.000264	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GRM4—bone cancer	0.00021	0.000264	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GRM4—bone cancer	0.00021	0.000264	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RGS1—bone cancer	0.00021	0.000264	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000209	0.000263	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—PLAU—bone cancer	0.000205	0.000259	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—PLAU—bone cancer	0.000205	0.000259	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—GNA11—bone cancer	0.000205	0.000258	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000202	0.000254	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000202	0.000254	CbGpPWpGaD
Bepridil—CALM3—Disease—ENO2—bone cancer	0.000199	0.000251	CbGpPWpGaD
Bepridil—PDE1A—Disease—MDM2—bone cancer	0.000199	0.00025	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GNA11—bone cancer	0.000198	0.00025	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—GNA11—bone cancer	0.000198	0.00025	CbGpPWpGaD
Bepridil—PDE1B—Immune System—MDM2—bone cancer	0.000197	0.000248	CbGpPWpGaD
Bepridil—CALM2—Disease—ENO2—bone cancer	0.000193	0.000243	CbGpPWpGaD
Bepridil—CALM1—Disease—ENO2—bone cancer	0.000193	0.000243	CbGpPWpGaD
Bepridil—PDE1A—Disease—PTGS2—bone cancer	0.000191	0.000241	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GRM1—bone cancer	0.000188	0.000236	CbGpPWpGaD
Bepridil—PDE1A—Immune System—JUN—bone cancer	0.000187	0.000235	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL3—bone cancer	0.000186	0.000234	CbGpPWpGaD
Bepridil—CALM3—Disease—DHFR—bone cancer	0.000185	0.000233	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GRM1—bone cancer	0.000182	0.000229	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GRM1—bone cancer	0.000182	0.000229	CbGpPWpGaD
Bepridil—PDE1B—Disease—MDM2—bone cancer	0.000182	0.000229	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL3—bone cancer	0.00018	0.000226	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL3—bone cancer	0.00018	0.000226	CbGpPWpGaD
Bepridil—CALM1—Disease—DHFR—bone cancer	0.000179	0.000225	CbGpPWpGaD
Bepridil—CALM2—Disease—DHFR—bone cancer	0.000179	0.000225	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KIT—bone cancer	0.000177	0.000222	CbGpPWpGaD
Bepridil—PDE1B—Disease—PTGS2—bone cancer	0.000175	0.00022	CbGpPWpGaD
Bepridil—CALM3—Immune System—ATF1—bone cancer	0.000174	0.000219	CbGpPWpGaD
Bepridil—PDE1B—Immune System—JUN—bone cancer	0.000171	0.000215	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KIT—bone cancer	0.00017	0.000214	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL3—bone cancer	0.00017	0.000214	CbGpPWpGaD
Bepridil—CALM1—Immune System—ATF1—bone cancer	0.000168	0.000212	CbGpPWpGaD
Bepridil—CALM2—Immune System—ATF1—bone cancer	0.000168	0.000212	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000168	0.000211	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ENO2—bone cancer	0.000167	0.00021	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—BRAF—bone cancer	0.000166	0.000209	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KIT—bone cancer	0.000165	0.000207	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KIT—bone cancer	0.000165	0.000207	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL3—bone cancer	0.000164	0.000207	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL3—bone cancer	0.000164	0.000207	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KIT—bone cancer	0.000163	0.000206	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KIT—bone cancer	0.000162	0.000203	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ENO2—bone cancer	0.000162	0.000203	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ENO2—bone cancer	0.000162	0.000203	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EGFR—bone cancer	0.000161	0.000203	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—EGFR—bone cancer	0.00016	0.000202	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KIT—bone cancer	0.000158	0.000199	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KIT—bone cancer	0.000158	0.000199	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—EGFR—bone cancer	0.000155	0.000195	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—EGFR—bone cancer	0.000155	0.000195	CbGpPWpGaD
Bepridil—CALM3—Metabolism—DHFR—bone cancer	0.000155	0.000195	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—BRAF—bone cancer	0.000152	0.000191	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—PTGS2—bone cancer	0.00015	0.000189	CbGpPWpGaD
Bepridil—CALM2—Metabolism—DHFR—bone cancer	0.00015	0.000189	CbGpPWpGaD
Bepridil—CALM1—Metabolism—DHFR—bone cancer	0.00015	0.000189	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EGFR—bone cancer	0.000147	0.000185	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EGFR—bone cancer	0.000147	0.000185	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GNA11—bone cancer	0.000145	0.000182	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000141	0.000178	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GNA11—bone cancer	0.00014	0.000176	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GNA11—bone cancer	0.00014	0.000176	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MDM2—bone cancer	0.000139	0.000175	CbGpPWpGaD
Bepridil—PDE1A—Disease—EGFR—bone cancer	0.000136	0.000171	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EGFR—bone cancer	0.000134	0.000169	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFBR2—bone cancer	0.000134	0.000169	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MDM2—bone cancer	0.000134	0.000169	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SMO—bone cancer	0.000132	0.000167	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—PTGS2—bone cancer	0.000132	0.000166	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CYP3A4—bone cancer	0.000131	0.000165	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFBR2—bone cancer	0.00013	0.000163	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFBR2—bone cancer	0.00013	0.000163	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MDM2—bone cancer	0.00013	0.000163	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MDM2—bone cancer	0.00013	0.000163	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—MDM2—bone cancer	0.000129	0.000162	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SMO—bone cancer	0.000128	0.000161	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SMO—bone cancer	0.000128	0.000161	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MDM2—bone cancer	0.000127	0.00016	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CYP3A4—bone cancer	0.000127	0.00016	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CYP3A4—bone cancer	0.000127	0.00016	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ENO2—bone cancer	0.000127	0.000159	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—MDM2—bone cancer	0.000124	0.000157	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—MDM2—bone cancer	0.000124	0.000157	CbGpPWpGaD
Bepridil—PDE1B—Disease—EGFR—bone cancer	0.000124	0.000156	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNA11—bone cancer	0.000121	0.000152	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—JUN—bone cancer	0.000121	0.000152	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ENO2—bone cancer	0.000119	0.00015	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MMP9—bone cancer	0.000118	0.000148	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—DHFR—bone cancer	0.000117	0.000148	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNA11—bone cancer	0.000117	0.000147	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNA11—bone cancer	0.000117	0.000147	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—JUN—bone cancer	0.000116	0.000147	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—JUN—bone cancer	0.000113	0.000142	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—JUN—bone cancer	0.000113	0.000142	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ATF1—bone cancer	0.000113	0.000142	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GSTP1—bone cancer	0.000112	0.000141	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—DHFR—bone cancer	0.000111	0.000139	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—JUN—bone cancer	0.000111	0.000139	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL3—bone cancer	0.00011	0.000138	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GNA11—bone cancer	0.00011	0.000138	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ATF1—bone cancer	0.000109	0.000137	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ATF1—bone cancer	0.000109	0.000137	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GSTP1—bone cancer	0.000109	0.000137	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GSTP1—bone cancer	0.000109	0.000137	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MMP9—bone cancer	0.000108	0.000135	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL3—bone cancer	0.000106	0.000134	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL3—bone cancer	0.000106	0.000134	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNA11—bone cancer	0.000103	0.00013	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CYP3A4—bone cancer	9.95e-05	0.000125	CbGpPWpGaD
Bepridil—CALM3—Immune System—KIT—bone cancer	9.91e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Immune System—KIT—bone cancer	9.58e-05	0.000121	CbGpPWpGaD
Bepridil—CALM1—Immune System—KIT—bone cancer	9.58e-05	0.000121	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—bone cancer	9.5e-05	0.00012	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFBR2—bone cancer	9.39e-05	0.000118	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CYP3A4—bone cancer	9.37e-05	0.000118	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—bone cancer	9.15e-05	0.000115	CbGpPWpGaD
Bepridil—CALM3—Disease—KIT—bone cancer	9.15e-05	0.000115	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFBR2—bone cancer	9.08e-05	0.000114	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFBR2—bone cancer	9.08e-05	0.000114	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—bone cancer	8.85e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—bone cancer	8.85e-05	0.000111	CbGpPWpGaD
Bepridil—CALM2—Disease—KIT—bone cancer	8.85e-05	0.000111	CbGpPWpGaD
Bepridil—CALM1—Disease—KIT—bone cancer	8.85e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1R—bone cancer	8.83e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—bone cancer	8.79e-05	0.000111	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—bone cancer	8.69e-05	0.000109	CbGpPWpGaD
Bepridil—CALM3—Disease—BRAF—bone cancer	8.6e-05	0.000108	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1R—bone cancer	8.54e-05	0.000108	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1R—bone cancer	8.54e-05	0.000108	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—bone cancer	8.54e-05	0.000107	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTP1—bone cancer	8.51e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—bone cancer	8.5e-05	0.000107	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—bone cancer	8.5e-05	0.000107	CbGpPWpGaD
Bepridil—CALM2—Disease—BRAF—bone cancer	8.32e-05	0.000105	CbGpPWpGaD
Bepridil—CALM1—Disease—BRAF—bone cancer	8.32e-05	0.000105	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—bone cancer	8.26e-05	0.000104	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—bone cancer	8.26e-05	0.000104	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTP1—bone cancer	8.02e-05	0.000101	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—bone cancer	7.98e-05	0.0001	CbGpPWpGaD
Bepridil—CALM3—Immune System—MDM2—bone cancer	7.8e-05	9.82e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MDM2—bone cancer	7.55e-05	9.5e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MDM2—bone cancer	7.55e-05	9.5e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—bone cancer	7.3e-05	9.19e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MDM2—bone cancer	7.2e-05	9.07e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MDM2—bone cancer	6.97e-05	8.77e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MDM2—bone cancer	6.97e-05	8.77e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—bone cancer	6.94e-05	8.74e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—JUN—bone cancer	6.78e-05	8.54e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—bone cancer	6.72e-05	8.46e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—bone cancer	6.72e-05	8.46e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—JUN—bone cancer	6.56e-05	8.26e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—JUN—bone cancer	6.56e-05	8.26e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KIT—bone cancer	6.4e-05	8.06e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—bone cancer	6.2e-05	7.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—bone cancer	6.2e-05	7.8e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BRAF—bone cancer	6.02e-05	7.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—bone cancer	5.83e-05	7.35e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BRAF—bone cancer	5.82e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BRAF—bone cancer	5.82e-05	7.33e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—bone cancer	5.81e-05	7.32e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—bone cancer	5.64e-05	7.11e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—bone cancer	5.64e-05	7.11e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—bone cancer	5.63e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—bone cancer	5.63e-05	7.08e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—bone cancer	5.33e-05	6.71e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—bone cancer	5.16e-05	6.49e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—bone cancer	5.16e-05	6.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—bone cancer	5.04e-05	6.35e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—bone cancer	4.92e-05	6.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—bone cancer	4.88e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—bone cancer	4.88e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—bone cancer	4.76e-05	5.99e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—bone cancer	4.76e-05	5.99e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—bone cancer	4.41e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JUN—bone cancer	4.38e-05	5.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—bone cancer	4.27e-05	5.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JUN—bone cancer	4.24e-05	5.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JUN—bone cancer	4.24e-05	5.34e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—bone cancer	4.15e-05	5.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—bone cancer	4.13e-05	5.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—bone cancer	4.13e-05	5.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—bone cancer	3.45e-05	4.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—bone cancer	3.33e-05	4.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—bone cancer	3.33e-05	4.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—bone cancer	2.89e-05	3.64e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—bone cancer	2.8e-05	3.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—bone cancer	2.8e-05	3.52e-05	CbGpPWpGaD
